Trending in drug discovery and biopharma - the best of 2019

SelectScience

From CRISPR screening in primary T cells to photodynamic therapy for curing cancer, we take a look back at research highlights and emerging technologies from the past year

9 Jan 2020

Sophie Ball

Publishing / Media

Editorial article

It has been another exciting year for SelectScience, connecting with experts and scientists around the world to promote the latest innovations in the drug discovery and development community. From special features to expert webinars to video interviews, rediscover some of the highlights 2019 had to offer as we take a look back at the best bits, including advances in biopharmaceutical research and small molecule design, and the applications of emerging technologies including cryo-electron microscopy, mass spectrometry and CRISPR.

Dr. Theodossis Theodossiou, Institute for Cancer Research, Oslo University Hospital

Latest in photodynamic therapy (PDT)

PDT is an exciting anti-cancer treatment, currently used clinically. In this video, Dr. Theodossis Theodossiou discusses his team’s cutting-edge research into curing cancer with photodynamic therapy (PDT).
Watch here>>

Discover a pipeline for pooled CRISPR screening in primary T cells

In this webinar, Cristina Ghirelli, immuno-oncology manager at Horizon Discovery, discusses the development of a pipeline to perform pooled CRISPR screening in primary T cells through a combined lentiviral and electroporation approach.
Watch now>>

Your guide to microplate readers

In this free eBook download, we guide you through buying a new microplate reader by providing expert insight and all the information you should consider to select the best technology for your lab.
Download guide>>

Unlock the secrets behind efficient CAR-T cell workflows
This SelectScience eBook aims to provide you with useful resources, expert insight, and application-based case studies to help simplify your choice when it comes to developing efficient, reproducible CAR-T cell workflows.
Download eBook>>

The key to faster biopharma analysis

Download this eBook to find more about the biopharmaceutical applications of the ACQUITY QDa Mass Detector and the BioAccord system from Waters.
Learn more>>

A new approach to small molecule drug discovery

Hear how the researchers working on the Perturbation of Protein-Protein Interactions (PoPPI) program are developing computational and chemical tools to design and synthesize new small molecule drugs that will target specific binding sites for selective inhibition of protein-protein interactions and how this approach may help develop new treatments for diseases, such as leukemia.
Watch here>>

Vote for your favorite Drug Discovery product

Have your say - vote for the Best New Drug Discovery & Development Product of 2019 from the shortlist. You'll also have the chance to win yourself a $500 Amazon.com Gift Card! But hurry - voting closes on Monday, January 20.
Vote now>>

The top-rated discovery products that earned a Seal of Quality

The top-rated lab products discovery scientists love the most were presented with well-earned Seals of Quality throughout the year. Discover the products your peers love most.
Read article>>

Dr. John Connolly, CSO of Tessa Therapeutics

Discover structure-based drug discovery with cryo-EM

In this application-based eBook, we outline the application of cryo-EM in structure-based drug discovery and look at how state-of-the-art microscopes, such as the Krios G4 cryo-TEM from Thermo Fisher Scientific, help to keep leaders in the pharmaceutical industry at the forefront of drug discovery.
Download eBook>>

Next-generation immunotherapy

Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors.
Read interview>>

Guide to long-term 3D spheroid culture and analysis

This application eBook demonstrates robust workflows for high-throughput spheroid assembly and long-term quantitative analysis.
Download eBook>>

Accelerating science

Last year, we received more lab product reviews than ever from scientists, sharing their knowledge and experiences to help their peers around the world.
Thank you to each and every one of you - we look forward to reading many more over the next 12 months.

Visit our Drug Discovery community for more of the latest>>

Related products

Request Quote for All Products

BioAccord LC-MS System
Waters
The First SmartMS-Enabled Biopharma Solution The Waters BioAccord System is an integrated system that simplifies high performance LC-MS biopharmaceutical analysis for every user. An easy-to-use system solution that puts the power to make decisions directly in your hands; a self-calibrating, self-optimizing, self-sufficient tool that equips you with high quality data you can use to tackle the challenges you face every day during biopharmaceutical development.
(15)
Glacios™ Cryo-TEM for Life Sciences
Thermo Fisher Scientific
The new Thermo Scientific™ Glacios™ Cryo Transmission Electron Microscope (Cryo-TEM) delivers a complete and affordable Cryo-EM solution to a broad range of scientists.
(0)
Krios G4 Cryo-TEM for Life Sciences
Thermo Fisher Scientific
The Thermo Scientific Krios G4 Cryo-Transmission Electron Microscope (Cryo-TEM) is a compact TEM. The instrument can be installed in labs with a ceiling height below 3.04 m (~10 ft), as the microscope height it below 3 meters. The Krios G4 Cryo-TEM has improved ergonomics for easier sample exchange. Data acquisition set up is easier and faster thanks to enhanced automation, systematic user guidance and advanced performance monitoring. Simultaneo
(0)
CLARIOstar® Plus Multi-mode Microplate Reader
BMG LABTECH
Most flexible Multi-mode Microplate Reader for Assay Development
(124)
ACQUITY QDa Mass Detector
Waters
The ACQUITY QDa® Mass Detector gives you certainty above all else. You can minimize the risk of unexpected coelutions or components and confirms trace components with the analytical confidence of mass detection. The ACQUITY QDa® Detector is a mass detector built around the needs of analytical scientists for chromatographic analysis. Robust, reliable and requiring no sample adjustments, it just integrates with your current LC, ACQUITY UPLC, ACQUITY UPC2 and purification systems. You'll enhance the analytical value and productivity of each analysis, and you won't need to run all the additional assays or time-consuming alternative techniques or even wait for results from specialist labs that cost your laboratory productivity. With the ACQUITY QDa® Detector, you now have information-rich mass spectral data to complement data from your current Waters® optical detectors, including the ACQUITY UPLC PDA, TUV, ELS, and FLR detectors, as well as the ACQUITY UPC² PDA Detector. This mass spectral information integrates seamlessly into the same workflow; routinely giving you more complete separation characterization. Features: Intuitive operation More information from every sample Effortless integration Increased efficiency Resolving complexity Applications: Food & Environment Life Sciences and Pharmaceuticals Chemical
(20)
Agilent BioTek MultiFlo FX Multimode Dispenser
Agilent Technologies
MultiFlo FX can dispense up to 4 independent reagents into 6- to 1536-well microplates.
(24)
Agilent BioTek Cytation 1 Cell Imaging Multimode Reader
Agilent Technologies
Cell Imaging Multi-Mode Reader
(3)
xCELLigence RTCA MP
Agilent Technologies
The Agilent xCELLigence Real-Time Cell Analysis (RTCA) MP instrument uses label-free cellular impedance to continuously monitor cell health, behavior, and function with high accuracy, sensitivity, and reproducibility. The MP model can host up to six 96-well electronic microplates (E-Plate 96), which can be run in parallel or independently of one another. This multiple plate format is ideal for cell health characterization, immune cell-mediated killing, viral cytopathic effects, cytotoxicity, cell adhesion, cell barrier function (TEER), cell signaling (e.g., GPCR) and other related applications. The instrument operates in a standard CO2 cell culture incubator and the control unit is housed outside the incubator. Simply plate cells and begin monitoring cell behavior to obtain real-time kinetic data for assay windows that stretch from seconds to days. Online data acquisition and offline data analysis are easy to perform using RTCA Software Pro, which also supports FDA 21 CFR Part 11. For Research Use Only. Not for use in diagnostic procedures.
(12)